Want to see GEHC full AI Analyst Report?

GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

1,875 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GEHC Analyst Ratings

Moderate Buy

8 Buy

5 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Healthcare Technologies Inc

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GEHC Stock 12 Month Forecast

Average Price Target

$78.62

▲(29.77% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for GE Healthcare Technologies Inc in the last 3 months. The average price target is $78.62 with a high forecast of $92.00 and a low forecast of $70.00. The average price target represents a 29.77% change from the last price of $60.58.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"$59","76":"$76","93":"$93","67.5":"$67.5","84.5":"$84.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$92.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":78.61538461538461,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$78.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$70.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,67.5,76,84.5,93],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.823,66.91353846153845,69.00407692307692,71.09461538461538,73.18515384615384,75.27569230769231,77.36623076923077,79.45676923076923,81.5473076923077,83.63784615384616,85.72838461538461,87.81892307692308,89.90946153846154,{"y":92,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.823,65.88395266272188,66.94490532544378,68.00585798816567,69.06681065088758,70.12776331360946,71.18871597633135,72.24966863905325,73.31062130177514,74.37157396449703,75.43252662721893,76.49347928994082,77.55443195266272,{"y":78.61538461538461,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.823,65.22123076923076,65.61946153846154,66.0176923076923,66.41592307692308,66.81415384615384,67.21238461538461,67.61061538461539,68.00884615384615,68.40707692307691,68.8053076923077,69.20353846153846,69.60176923076924,{"y":70,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":75.771,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.717,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.589,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.366,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.841,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.125,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.901,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.025,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.075,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.904,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.995,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.654,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.823,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$92.00

Average Price Target$78.62

Lowest Price Target$70.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Graham Doyle

UBS

$67→$73

Hold

20.50%

Upside

Assigned

07/31/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Bristol-Myers Squibb (NYSE: BMY) and Stryker (NYSE: SYK)

Matthew Taylor

Jefferies

$90→$92

Buy

51.87%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Omnicell (NASDAQ: OMCL), Daiichi Sankyo Company (Other OTC: DSKYF) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Suraj Kalia

Oppenheimer

$85

Buy

40.31%

Upside

Reiterated

07/30/26

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Oppenheimer

Robbie Marcus

J.P. Morgan

$65→$70

Hold

15.55%

Upside

Assigned

07/30/26

GE HealthCare price target raised to $70 from $65 at JPMorganGE HealthCare price target raised to $70 from $65 at JPMorgan

Vijay Kumar

Evercore ISI

$80→$84

Buy

38.66%

Upside

Reiterated

07/30/26

GE HealthCare price target raised to $84 from $80 at Evercore ISIGE HealthCare price target raised to $84 from $80 at Evercore ISI

Larry Biegelsen

Wells Fargo

$75→$85

Buy

40.31%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Vik Chopra

BMO Capital

$70→$71

Hold

17.20%

Upside

Reiterated

07/30/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (NASDAQ: BIIB), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Fortrea Holdings Inc. (NASDAQ: FTRE)

Rick Wise

Stifel Nicolaus

$80

Buy

32.06%

Upside

Reiterated

07/30/26

Stifel Nicolaus Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Ryan Zimmerman

BTIG

$75→$79

Buy

30.41%

Upside

Reiterated

07/29/26

GE HealthCare price target raised to $79 from $75 at BTIGGE HealthCare price target raised to $79 from $75 at BTIG

Joanne Wuensch

Citi

$69→$75

Hold

23.80%

Upside

Assigned

07/29/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Biogen (NASDAQ: BIIB) and Vaxcyte (NASDAQ: PCVX)

Travis Steed

Bank of America Securities

$74

Hold

22.15%

Upside

Reiterated

07/29/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Humana (NYSE: HUM) and Ocular Therapeutix (NASDAQ: OCUL)

Jason Bednar

Piper Sandler

$74

Buy

22.15%

Upside

Reiterated

07/24/26

Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Edwards Lifesciences (EW)

Anthony Petrone

Mizuho Securities

$90→$80

Buy

32.06%

Upside

Reiterated

04/30/26

Mizuho Securities Remains a Buy on GE Healthcare Technologies Inc (GEHC)

Matt Miksic

Barclays

$87→$78

Hold

28.76%

Upside

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE), Ionis Pharmaceuticals (NASDAQ: IONS) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

David Roman

Goldman Sachs

―

Hold

―

Downgraded

04/30/26

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Crescent Biopharma (NASDAQ: CBIO)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Graham Doyle

UBS

$67→$73

Hold

20.50%

Upside

Assigned

07/31/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Bristol-Myers Squibb (NYSE: BMY) and Stryker (NYSE: SYK)

Matthew Taylor

Jefferies

$90→$92

Buy

51.87%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Omnicell (NASDAQ: OMCL), Daiichi Sankyo Company (Other OTC: DSKYF) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Suraj Kalia

Oppenheimer

$85

Buy

40.31%

Upside

Reiterated

07/30/26

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Oppenheimer

Robbie Marcus

J.P. Morgan

$65→$70

Hold

15.55%

Upside

Assigned

07/30/26

GE HealthCare price target raised to $70 from $65 at JPMorganGE HealthCare price target raised to $70 from $65 at JPMorgan

Vijay Kumar

Evercore ISI

$80→$84

Buy

38.66%

Upside

Reiterated

07/30/26

GE HealthCare price target raised to $84 from $80 at Evercore ISIGE HealthCare price target raised to $84 from $80 at Evercore ISI

Larry Biegelsen

Wells Fargo

$75→$85

Buy

40.31%

Upside

Reiterated

07/30/26

Analysts Offer Insights on Healthcare Companies: Teladoc (NYSE: TDOC) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Vik Chopra

BMO Capital

$70→$71

Hold

17.20%

Upside

Reiterated

07/30/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Biogen (NASDAQ: BIIB), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Fortrea Holdings Inc. (NASDAQ: FTRE)

Rick Wise

Stifel Nicolaus

$80

Buy

32.06%

Upside

Reiterated

07/30/26

Stifel Nicolaus Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Ryan Zimmerman

BTIG

$75→$79

Buy

30.41%

Upside

Reiterated

07/29/26

GE HealthCare price target raised to $79 from $75 at BTIGGE HealthCare price target raised to $79 from $75 at BTIG

Joanne Wuensch

Citi

$69→$75

Hold

23.80%

Upside

Assigned

07/29/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Biogen (NASDAQ: BIIB) and Vaxcyte (NASDAQ: PCVX)

Travis Steed

Bank of America Securities

$74

Hold

22.15%

Upside

Reiterated

07/29/26

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Humana (NYSE: HUM) and Ocular Therapeutix (NASDAQ: OCUL)

Jason Bednar

Piper Sandler

$74

Buy

22.15%

Upside

Reiterated

07/24/26

Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Edwards Lifesciences (EW)

Anthony Petrone

Mizuho Securities

$90→$80

Buy

32.06%

Upside

Reiterated

04/30/26

Mizuho Securities Remains a Buy on GE Healthcare Technologies Inc (GEHC)

Matt Miksic

Barclays

$87→$78

Hold

28.76%

Upside

Reiterated

04/30/26

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (NYSE: HNGE), Ionis Pharmaceuticals (NASDAQ: IONS) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

David Roman

Goldman Sachs

―

Hold

―

Downgraded

04/30/26

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (NYSE: TEVA), GE Healthcare Technologies Inc (NASDAQ: GEHC) and Crescent Biopharma (NASDAQ: CBIO)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

AMLXAmylyx Pharmaceuticals Inc

ZURAZura Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GE Healthcare Technologies Inc

3 Months

Suraj KaliaOppenheimer

Success Rate

6/9 ratings generated profit

Average Return

+3.36%

Copying Suraj Kalia's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +3.36% per trade.

1 Year

Suraj KaliaOppenheimer

Success Rate

5/9 ratings generated profit

Average Return

+1.69%

Copying Suraj Kalia's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +1.69% per trade.

2 Years

Suraj KaliaOppenheimer

Success Rate

3/9 ratings generated profit

Average Return

-3.37%

Copying Suraj Kalia's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -3.37% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GEHC Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GEHC has received 19 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. GEHC average Analyst price target in the past 3 months is 78.62.

Each month's total comprises the sum of three months' worth of ratings.

GEHC Financial Forecast

GEHC Earnings Forecast

Next quarter’s earnings estimate for GEHC is $1.20 with a range of $1.18 to $1.25. The previous quarter’s EPS was $1.13. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 40.44% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Sales Forecast

Next quarter’s sales forecast for GEHC is $5.35B with a range of $5.28B to $5.43B. The previous quarter’s sales results were $5.29B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 38.92% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Stock Forecast FAQ

What is GEHC’s average 12-month price target, according to analysts?

Based on analyst ratings, Ge Healthcare Technologies Inc.’s 12-month average price target is 78.62.

What is GEHC’s upside potential, based on the analysts’ average price target?

Ge Healthcare Technologies Inc. has 29.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GEHC a Buy, Sell or Hold?

Ge Healthcare Technologies Inc. has a consensus rating of Moderate Buy which is based on 8 buy ratings, 5 hold ratings and 0 sell ratings.

What is Ge Healthcare Technologies Inc.’s price target?

The average price target for Ge Healthcare Technologies Inc. is 78.62. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $92.00 ,the lowest forecast is $70.00. The average price target represents 29.77% Increase from the current price of $60.58.

What do analysts say about Ge Healthcare Technologies Inc.?

Ge Healthcare Technologies Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of GEHC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

GEHC Analyst Ratings

GEHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GE Healthcare Technologies Inc

GEHC Analyst Recommendation Trends

GEHC Financial Forecast

GEHC Earnings Forecast

GEHC Sales Forecast

GEHC Stock Forecast FAQ

Detailed List of Analyst Forecasts